Clinical Trial Update: Ustekinumab With Semi-EN vs Exclusive EN for Preoperative Crohn's Disease Optimization. [NA]

View source ↗

Summary

A clinical trial comparing ustekinumab with semi-elemental enteral nutrition versus exclusive enteral nutrition for preoperative optimization in Crohn's disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Xiang Gao | Conditions: Crohn Disease (CD) | NA | Status: RECRUITING